-
-
-
-
-
-
-
Bruker Introduces iNTApharma™, a Label‑Free Platform for Nanoparticle Characterization in mRNA Drug and Gene Therapy Development and QC
-
-
-
-
-
-
-
Bruker Announces Second Quarter 2025 Preliminary Results, Plans to Hold Q2 Earnings Conference Call on August 4, 2025
-
-
-
-
-
-
-
Bruker Reports First Quarter 2025 Financial Results
-
-
-
-
-
-
-
Bruker Reports Third Quarter 2024 Financial Results
-
-
-
-
-
-
-
Biognosys Enters Reselling Agreement for Spectronaut Proteomics Software with Leading Provider of Mass Spectrometry Systems
-
-
-
-
-
-
-
Bruker Completes Asset Acquisition of NanoString Business
-
-
-
-
-
-
-
Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research
-
1,160,146 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

